Agilent provides xCELLigence impedance-based, label-free, real time cell analysis system and NovoCyte flow cytometers.
Automated microscopy and image analysis
Real-time, label free cell analysis
Nano and micro particle analysis
Accelerate to discover
Back to filter
Show all topics (10)
Related topics
Intoducing spheroOne: Automated sorting and isolation of single spheroids and organoids
Jun 21, 2022
spheroONE is an innovative single large-particle sorter and dispenser which revolutionizes 3D cellular models handling....
Outstanding post-sort sample recovery on the WOLF Cell Sorter
Jun 14, 2022
The new WOLF G2 instrument has significantly expanded the capabilities of gentle benchtop microfluidic cell sorting...
Incucyte AI module: Advanced Label-Free Classification Analysis
Jun 6, 2022
Monitor adherent cell morphology changes objectively to determine live/dead cell counts or classify cells based on...
Favipiravir at high doses has potent antiviral activity in SARS-CoV-2−infected hamsters
Jun 3, 2022
Favipiravir at high doses has potent antiviral activity in SARS-CoV-2−infected hamsters, whereas hydroxychloroquine...
An experimental strategy for preparing circular ssDNA virus genomes for next-generation sequencing
Jun 1, 2022
Recent article from February 2022 shoes how size selection improved viral read mapping by over 90% for begomoviruses.
Intoducing cellenONE: The revolutionary Single Cell isolator
May 25, 2022
A revolutionary platform based on sciDROP PICO precision dispensing technology and coupled with advanced image...
Advances in Leukemia research using shear flow and Bioflux system
May 24, 2022
Leukemia is a rare cancer with many subtypes. The production of abnormal leukocytes create disruptions in the immune...
Extracellular Vesicle Purity Enhanced by Gen 2 qEV Columns With Customised Proprietary Resin
May 4, 2022
Izon Science has announced the launch of Gen 2, the enhanced range of qEV columns for size-exclusion...
New technique for dynamic monitoring of liquid tumor Cytotoxicity
Feb 12, 2019
If you are currently measuring the killing potency of an immunotherapy targeting liquid cancer cells using traditional endpoint assays such as Cr51 release and LDH assays, you are missing key elements of tumor cytotoxicity. Cancer-killing effectors do not always kill the targets at a constant pace. Have you optimized the incubation time of the effector/target co-culture and collect the readout at the peak of each cytotoxicity reaction.
We are excited to share the latest application note for xCELLigence Real Time Cell Analysis: "Evaluating Functional Potency of Immunotherapies Targeting Tumors of B Cell Origin." The application note explains the principle of measuring the cytotoxicity of liquid tumors such as lymphoma, leukemia or myeloma continuously, in real-time and with unprecedented details. Key benefits include:
• Radiation-free
• Substantially reduced workload - just add effectors to targets and you are all set
• Continuous in real-time
• Assay windows spanning minutes to days
• Low, physiologically relevant effector:target ratios
Related technologies: Real-time, label free cell analysis
Get more info
Brand profile
